Search clinical trials for: buserelin

Total 302 results

University of British Columbia

Unknown

Androgen Suppression Combined With Elective Nodal and Dose Escalated Radiation Therapy

Prostate Cancer

Canada
UNICANCER
Janssen Pharmaceutica

Recruiting

Combined Apalutamide, Radiotherapy, and LHRH Agonist in Prostate Cancer Patients After Prostatectomy (CARLHA-2)

Prostate Cancer

France
Novartis Pharmaceuticals

Completed

A Phase Ib Dose Escalation Study of the Combination of LEE011 With Letrozole and Dose Expansion of LEE011 With Hormonal Therapy for the Treatment of Pre-(With Goserelin) and Postmenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer

Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer

Japan, Hong Kong, Singapore
Hoffman Oncology
DSCS CRO

Active, not recruiting

Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer

Breast Cancer

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer

Prostate Cancer

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer

Prostate Cancer

United States
AstraZeneca

Completed

Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment

Breast Cancer

Japan
University of Sao Paulo

Unknown

Evaluation of the Luteolytic Effect of a Gonadotropin Releasing Hormone (GnRH) Agonist After the Administration of Human Chorionic Gonadotropin (hCG) in the Initial Follicular Phase a Its Influence on the Prognosis of in Vitro Fertilization Treatment

Infertility

Brazil
AstraZeneca

Withdrawn

CMAB vs IMAB in Metastatic Prostate Cancer

Metastatic Prostate Cancer

Mexico
Cougar Biotechnology, Inc.

Completed

Neo-adjuvant Abiraterone + Luteinizing Hormone-Releasing Hormone (LHRH) Versus LHRH in Prostate Cancer

Prostate Cancer

United States
University of Chicago
National Cancer Institute (NCI)

Completed

SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

Prostate Cancer

United States
Pfizer

Completed

Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland

Metastatic Castration Resistant Prostate Cancer (mCRPC) | Metastatic Castration Sensitive Prostate Cancer (mCSPC)

Finland
Austrian Breast & Colorectal Cancer Study Group
AstraZeneca; Novartis Pharmaceuticals

Completed

Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid

Breast Cancer

Austria, Germany
Southwest Oncology Group
National Cancer Institute (NCI); Cancer and Leukemia Group B

Completed

S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer

Prostate Cancer

United States
Fudan University

Active, not recruiting

Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery)

Prostate Cancer

China
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)

Completed

LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate Cancer

Recurrent Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Sanofi

Terminated

Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA

Prostate Cancer

United States
Ferring Pharmaceuticals

Completed

Investigation of the Effect of Degarelix in Terms of Prostate Volume Reduction in Prostate Cancer Patients

Prostate Cancer

Belgium, Italy, Sweden, Portugal, Denmark, Finland, Norway, Turkey
Ferring Pharmaceuticals

Terminated

Symptomatic Study Investigating Degarelix in Patients Suffering From Prostate Cancer

Prostate Cancer

Spain, United Kingdom, Germany
University College, London
Medical Research Council

Unknown

Prostate Adenocarcinoma TransCutaneous Hormones (PATCH)

Anemia | Hot Flashes | Prostate Cancer | Osteoporosis | Cardiovascular Complications

United Kingdom
University of Washington

Completed

Study of Effectiveness of IMC-A12 Antibody Combined With Hormone Therapy Prior to Surgery to Treat Prostate Cancer

Prostate Cancer

United States
Ferring Pharmaceuticals

Completed

Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer

Prostate Cancer

Spain, France, United States, Greece, United Kingdom, Germany, Netherlands
Xiao X. Wei, MD
Bristol-Myers Squibb

Active, not recruiting

Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors

Prostate Adenocarcinoma | Hormone Sensitive Prostate Cancer | Metastasis Prostate Adenocarcinoma

United States
National Cancer Institute (NCI)

Terminated

Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast Cancer

Recurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | HER2/Neu Negative

United States
Thomas Hatschek

Active, not recruiting

Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors (PREDIX LumA)

Early-Stage Breast Carcinoma | Hormone Receptor Positive Tumor

Sweden
AstraZeneca

Active, not recruiting

A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.

Advanced Prostate Cancer

China
Assiut University

Unknown

Fulvestrant in Metastatic Breast Cancer

Metastatic Breast Cancer
Institut Paoli-Calmettes
Novartis

Terminated

Dose Finding Study of BKM 120 in Combination With LH-RH Agonists and Bicalutamide in Men With Non Castrate Metastatic Prostate Cancer (NCMPC-BKM)

Non Castrate Metastatic Prostate Cancer

France
Instituto do Cancer do Estado de São Paulo
Janssen, LP

Completed

Neoadjuvant Androgen Deprivation Therapy Plus Abiraterone With or Without Apalutamide for High-Risk Prostate Cancer

Prostate Cancer

Brazil
Washington University School of Medicine
Genomic Health®, Inc.

Recruiting

Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score

Breast Cancer | Breast Neoplasms | Cancer of Breast | Cancer of the Breast

United States
Novartis Pharmaceuticals

Terminated

Pilot Decentralized Clinical Trial in Men and Pre and Post-menopausal Women With Breast Cancer and a Specific Mutation (PIK3CA) Treated With Alpelisib in Combination With Fulvestrant (TELEPIK)

Advanced Breast Cancer

Sweden
Beth Israel Deaconess Medical Center
Walter Reed Army Medical Center

Completed

Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer

Prostate Cancer

United States
Debiopharm International SA
Quintiles, Inc.

Completed

Study on Efficacy, Pharmacokinetics, and Safety of Two Subcutaneous Injections of Triptorelin Embonate 6 Month Formulation in Patients With Advanced Prostate Cancer

Prostate Cancer

South Africa
University of Nebraska
American College of Sports Medicine

Completed

Strength, Aging, and Memory in Prostate Cancer (STAMP)

Prostate Cancer | Prostate Neoplasm

United States
Shengjing Hospital

Not yet recruiting

Chidamide Combined With Exemestane (+/- Goserelin) Versus Neoadjuvant Chemotherapy in Patients of Stage II-III HR-positive/HER2-negative Breast Cancer

Breast Neoplasms
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases

Prostate Cancer | Metastatic Cancer

United States
Wonju Severance Christian Hospital
Eulji University Hospital

Recruiting

Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer Patients

Prostatic Neoplasms

Korea, Republic of
Eastern Cooperative Oncology Group
National Cancer Institute (NCI); Southwest Oncology Group; Cancer and Leukemia...

Completed

Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer

Prostate Cancer

United States
Cancer Research Antwerp
Bayer; Veracyte, Inc.

Recruiting

Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers (THUNDER)

Prostate Cancer

Belgium
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer

Prostate Cancer

United States
RTOG Foundation, Inc.
Pfizer; Astellas Pharma Inc

Active, not recruiting

A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery (STEEL)

Prostate Cancer

United States, Canada
National Cancer Institute (NCI)

Terminated

Leuprolide Acetate or Goserelin Acetate With or Without Vismodegib Followed by Surgery in Treating Patients With Locally Advanced Prostate Cancer

Prostate Adenocarcinoma | Stage IIA Prostate Cancer AJCC v7 | Stage IIB Prostate Cancer AJCC v7

United States
University of Washington
National Cancer Institute (NCI)

Completed

Abiraterone Prednisone and Hormonal Therapy Before and During Radiation Therapy in Localized Prostate Cancer (RAD1)

Stage II Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer

United States
Latin American Cooperative Oncology Group
Janssen Pharmaceuticals

Completed

Study of Abiraterone Acetate Plus ADT Versus APALUTAMIDE Versus Abiraterone and APALUTAMIDE in Patients With Advanced Prostate Cancer With Non-castrate Testosterone Levels

Prostate Cancer

Brazil
Peking Union Medical College Hospital

Not yet recruiting

Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced Amenorrhoea

Breast Cancer | Chemotherapy Induced Amenorrhea | Ovarian Function Suppression

China
National Taiwan University Hospital

Recruiting

Immunotherapy, Hormone Therapy, and AKT Inhibitor for Premenopausal ER Positive MBC

Metastatic Breast Cancer | Premenopausal Breast Cancer | ER Positive Breast Cancer

Taiwan
Vanderbilt-Ingram Cancer Center

Withdrawn

MK-2206+Endocrine Therapy in Patients With Hormone Receptor-Positive Breast Cancer

Metastatic Breast Cancer
Stanford University
National Cancer Institute (NCI)

Active, not recruiting

High-Dose Brachytherapy in Treating Patients With Prostate Cancer

Prostate Adenocarcinoma | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer

United States
Zhejiang Cancer Hospital

Completed

Zoladex Plus Tamoxifen in Breast Cancer

Ultrasonography | Lipemia | Endometrium | Mammography | Estrogen

China
Novartis Pharmaceuticals

Completed

Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast Cancer (RIGHT Choice)

Breast Cancer

India, Malaysia, Saudi Arabia, Taiwan, Russian Federation, Lebanon, South Africa, Thailand, Jordan, Turkey, Egypt, Vietnam, Singapore

Search clinical trials for: buserelin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations